Patients with pathological stage N2 rectal cancer treated with early adjuvant chemotherapy have a lower treatment failure rate

BACKGROUND: In this era of oxaliplatin-based adjuvant therapy, the optimal sequence in which chemoradiotherapy should be administered for pathological stage N2 rectal cancer is unknown. The aim of this study was to investigate this sequence. METHODS: In the primary adjuvant concurrent chemoradiother...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Yan-Ru, Jin, Jing, Ren, Hua, Wang, Xin, Wang, Shu-Lian, Wang, Wei-Hu, Song, Yong-Wen, Liu, Yue-Ping, Tang, Yuan, Li, Ning, Liu, Xin-Fan, Fang, Hui, Yu, Zi-Hao, Li, Ye-Xiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343389/
https://www.ncbi.nlm.nih.gov/pubmed/28279170
http://dx.doi.org/10.1186/s12885-017-3170-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343389/
https://www.ncbi.nlm.nih.gov/pubmed/28279170
http://dx.doi.org/10.1186/s12885-017-3170-3

Ejemplares similares